Scott Weaver to Virus Replication
This is a "connection" page, showing publications Scott Weaver has written about Virus Replication.
Connection Strength
0.135
-
Host oxidative folding pathways offer novel anti-chikungunya virus drug targets with broad spectrum potential. Antiviral Res. 2017 07; 143:246-251.
Score: 0.037
-
A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence. Cell. 2021 04 15; 184(8):2229-2238.e13.
Score: 0.012
-
Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis. Nature. 2021 03; 591(7849):293-299.
Score: 0.012
-
Spike mutation D614G alters SARS-CoV-2 fitness. Nature. 2021 04; 592(7852):116-121.
Score: 0.012
-
Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. 2020 06; 26(6):1266-1273.
Score: 0.012
-
An Infectious cDNA Clone of SARS-CoV-2. Cell Host Microbe. 2020 05 13; 27(5):841-848.e3.
Score: 0.011
-
Neutralizing Antibodies Inhibit Chikungunya Virus Budding at the Plasma Membrane. Cell Host Microbe. 2018 09 12; 24(3):417-428.e5.
Score: 0.010
-
Novel Insect-Specific Eilat Virus-Based Chimeric Vaccine Candidates Provide Durable, Mono- and Multivalent, Single-Dose Protection against Lethal Alphavirus Challenge. J Virol. 2018 02 15; 92(4).
Score: 0.010
-
Functional Analysis of Glycosylation of Zika Virus Envelope Protein. Cell Rep. 2017 Oct 31; 21(5):1180-1190.
Score: 0.010
-
Viral Retinopathy in Experimental Models of Zika Infection. Invest Ophthalmol Vis Sci. 2017 08 01; 58(10):4355–4365.
Score: 0.009